SLO Stock Chart & Stats
€24.80
€0.00(0.00%)
At close: 4:00 PM EST
€24.80
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€21.40 - €43.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€360.19M
Enterprise Value€48.48K
Total Cash (Recent Filing)€14.82B
Total Debt (Recent Filing)€5.75B
Price to Earnings (P/E)20.0
Beta0.60
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)258.39
Shares Outstanding12,973,248
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio2.57
Price to Book (P/B)1.19
Price to Sales (P/S)1.55
P/FCF Ratio39.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.5
Revenue Forecast (FY)€213.76M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetConsistently low leverage and a rising equity base give the company durable financial resilience. This balance-sheet strength supports ongoing investment in high-purity production capacity, cushions semiconductor demand swings, preserves access to credit, and reduces insolvency risk across cycles.
Improving Margins And Revenue RecoveryMargins recovered materially after the downturn, reflecting better pricing, mix, or cost control. Sustained higher gross and EBIT margins enhance ability to fund R&D, quality control and capital spending critical for specialty fluorine chemicals, improving long-term competitiveness and cash generation.
Consistent Operating Cash GenerationHealthy operating cash flow over multiple years indicates the business generates real cash from operations. That supports ongoing capex for high-purity production, regular working-capital needs and steady shareholder returns or deleveraging, even if free cash flow varies year-to-year.
Bears Say
Volatile Free Cash FlowFree cash flow swings driven by working-capital and capex variability reduce predictability of funds available for dividends, buybacks or strategic M&A. That volatility constrains long-term capital allocation planning and increases sensitivity to near-term capex timing or receivables cycles.
Cyclical Earnings Below Prior PeakProfitability shows cyclicality tied to end-market demand; current margins are well below peak years. Persistent cyclicality makes sustainable ROE and earnings forecasts less certain, complicating long-horizon investment decisions and increasing downside during semiconductor slowdowns.
End-market Concentration RiskA large share of revenue depends on semiconductor/electronics production cycles. This concentration exposes the company to customer capex swings, tech transitions and industry consolidation, which can materially affect order volumes and long-term revenue stability despite some diversification into other industrial uses.
Stella Chemifa News
SLO FAQ
What was Stella Chemifa Corporation’s price range in the past 12 months?
Stella Chemifa Corporation lowest stock price was €21.40 and its highest was €43.40 in the past 12 months.
What is Stella Chemifa Corporation’s market cap?
Stella Chemifa Corporation’s market cap is €360.19M.
When is Stella Chemifa Corporation’s upcoming earnings report date?
Stella Chemifa Corporation’s upcoming earnings report date is Aug 06, 2026 which is in 3 days.
How were Stella Chemifa Corporation’s earnings last quarter?
Stella Chemifa Corporation released its earnings results on May 14, 2026. The company reported €0.301 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Stella Chemifa Corporation overvalued?
According to Wall Street analysts Stella Chemifa Corporation’s price is currently Overvalued.
Does Stella Chemifa Corporation pay dividends?
Stella Chemifa Corporation does not currently pay dividends.
What is Stella Chemifa Corporation’s EPS estimate?
Stella Chemifa Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stella Chemifa Corporation have?
Stella Chemifa Corporation has 12,973,248 shares outstanding.
What happened to Stella Chemifa Corporation’s price movement after its last earnings report?
Stella Chemifa Corporation reported an EPS of €0.301 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.938%.
Which hedge fund is a major shareholder of Stella Chemifa Corporation?
Currently, no hedge funds are holding shares in DE:SLO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Stella Chemifa Corporation
Stella Chemifa Corporation, a Japanese company established in 1916 and headquartered in Osaka, specializes as a global manufacturer and supplier of inorganic fluorine compounds. Formerly known as Hashimoto Chemical Corporation until its rebranding in 1997, the company offers a comprehensive product portfolio tailored for diverse industrial applications worldwide. For the electronics sector, Stella Chemifa provides essential materials such as hydrofluoric acid, buffered hydrofluoric acid, and various etching solutions used in the production of semiconductors, liquid crystal displays, and solar cells. It also supplies a range of metal fluorides, including calcium, aluminum, and lithium fluoride, crucial for optical applications, alongside lithium hexafluorophosphate for battery manufacturing. Its offerings extend to numerous boron trifluoride compounds, serving as vital reactive catalysts across different chemical processes. Additionally, the company produces anhydrous hydrofluoric acid and 55% hydrofluoric acid, utilized in surface treatment and as more environmentally conscious alternatives to CFCs. Stella Chemifa also supports the nuclear energy industry with potassium fluoroborate and boric acid, and provides tin fluoride (II) USP for products requiring GMP compliance. Beyond these specialized compounds, the company's extensive catalog includes a broad array of other fluorochemicals, such as fluorosilicic acid, various fluorosilicates, fluoroboric acid, diverse fluoroborates, and a selection of ammonium, sodium, and potassium fluorides. Complementing its manufacturing operations, Stella Chemifa offers logistics services for the transportation of specialized chemical substances, high-pressure gases, and hazardous materials. Demonstrating a commitment to innovation, the company is also actively involved in the development of Boron Neutron Capture therapy for cancer treatment.
Technical Analysis
Osaka Organic Chemical Industry Ltd.
―
Sumitomo Seika Chemicals Co., Ltd.
―
Sakai Chemical Industry Co., Ltd.
―
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
―
Nippon Fine Chemical Co., Ltd.
―




